Valter Gattei

Valter Gattei publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Valter Gattei sits on this spectrum.

Valter Gattei D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Valter Gattei sits on this spectrum.

Best Publications

• Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

  Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  782
  Citations

• Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

  Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  601
  Citations

• Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

  Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  564
  Citations

• Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

  Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  485
  Citations

• The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

  Davide Rossi;Valeria Spina;Clara Deambrogi;Silvia Rasi

  441
  Citations

• The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

  Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  439
  Citations

• Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

  Davide Rossi;Hossein Khiabanian;Valeria Spina;Carmela Ciardullo

  415
  Citations

• The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

  Davide Rossi;Michaela Cerri;Clara Deambrogi;Elisa Sozzi

  415
  Citations

• Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

  Davide Rossi;Marco Fangazio;Silvia Rasi;Tiziana Vaisitti

  400
  Citations

• Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

  Valter Gattei;Pietro Bulian;Maria Ilaria Del Principe;Antonella Zucchetto

  328
  Citations

• Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.

  Davide Rossi;Michaela Cerri;Daniela Capello;Clara Deambrogi

  296
  Citations

• Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

  Ekaterina Chigrinova;Andrea Rinaldi;Ivo Kwee;Ivo Kwee;Davide Rossi

  293
  Citations

• Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

  Davide Rossi;Valeria Spina;Michaela Cerri;Silvia Rasi

  263
  Citations

• Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.

  Davide Rossi;Lodovico Terzi-di-Bergamo;Lorenzo De Paoli;Michaela Cerri

  257
  Citations

• CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

  Pietro Bulian;Tait D. Shanafelt;Chris Fegan;Antonella Zucchetto

  252
  Citations

• Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

  Maria Ilaria Del Principe;Giovanni Del Poeta;Francesco Buccisano;Luca Maurillo

  236
  Citations

• Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.

  A Carbone;A Gloghini;V Gattei;D Aldinucci

  232
  Citations

• Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

  Andrea Rinaldi;Michael Mian;Ekaterina Chigrinova;Luca Arcaini

  213
  Citations

• The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.

  Davide Rossi;Elisa Sozzi;Alessia Puma;Lorenzo De Paoli

  191
  Citations

• Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line

  Antonio Pinto;Donatella Aldinucci;Annunziata Gloghini;Vittorina Zagonel

  187
  Citations